RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ROSTI G
Collezione AOU Alessandria

Items : 5

The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2024 May;24(5):323-331. doi: 10.1016/j.clml.2024.01.008. Epub 2024 Jan 2

2024
AOU Alessandria
AOU San Luigi di Orbassano

Butturini G; Bernardi S; Farina M; Defina M; Russo S; Russo Rossi A; Tiribelli M; Romano A; De Gobbi M; Corsetti MT; Sancetta R; Coppi MR; Lemoli RM; Rosti G; Castagnetti F; Lunghi F; Crugnola M; Ferrari ML; Lunghi M; D'Adda M; Stagno F; Binotto G; Abruzzese E; Bonifacio M; Bucelli C; Iurlo A; Malagola M; Pellizzeri S; Roccaro AM; et alii...

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study. in Cancer medicine / Cancer Med. 2021 Mar;10(5):1726-1737. doi: 10.1002/cam4.3778. Epub 2021 Feb 16.

2021
AOU Alessandria
AOU San Luigi di Orbassano

Bernardi S; Farina M; Gandolfi L; Bocchia M; Aprile L; Russo S; Russo Rossi A; Romano A; Tiribelli M; Rege Cambrin G; Corsetti MT; Coppi MR; Sancetta R; Lemoli RM; Rosti G; Castagnetti F; Lunghi F; Ferrari ML; Crugnola M; D'Adda M; Lunghi M; Binotto G; Stagno F; Abruzzese E; Bonifacio M; Iurlo A; Malagola M; Polverelli N; Roccaro AM; et alii...

A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation. in Journal of clinical medicine / J Clin Med. 2020 Nov 17;9(11):3692. doi: 10.3390/jcm9113692.

2020
AOU Alessandria

Dragani M; Rege Cambrin G; Berchialla P; Dogliotti I; Rosti G; Castagnetti F; Capodanno I; Martino B; Cerrano M; Ferrero D; Gambacorti-Passerini C; Crugnola M; Elena C; Breccia M; Iurlo A; Cattaneo D; Galimberti S; Gozzini A; Bocchia M; Lunghi F; Cedrone M; Sgherza N; Luciano L; Russo S; Santoro M; Giai V; Caocci G; Levato L; Abruzzese E; et alii...

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Alessandria
AOU Città della Salute di Torino

Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Palmieri F; Musolino C; Montefusco E; Melpignano A; Miggiano MC; Martino B; Marasca R; Malagola M; Lunghi M; Lunghi F; Luciano L; Lucchesi A; Levato L; La Barba G; Iurlo A; Gozzini A; Gugliotta G; Giai V; Galimberti S; Fozza C; Fazi P; Fava C; Elena C; D'Adda M; Crugnola M; et alii...

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice. in Haematologica / Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.

2019
AOU Alessandria
AOU Città della Salute di Torino

Saglio G; Ferrero D; Baccarani M; Pane F; Specchia G; Lunghi F; Sorà F; Iuliano F; Caocci G; Russo S; Musto P; Luciano L; Sgherza N; Giai V; Cavazzini F; Stagno F; Levato L; Annunziata M; Santoro M; Cedrone M; Breccia M; Latagliata R; Cattaneo D; Iurlo A; Bocchia M; Galimberti S; Rapezzi D; Crugnola M; Bergamaschi M; et alii...